First patient randomised in a Phase 2A, Proof of Concept (PoC) clinical trial of SUVN-G3031
The trial is taking place for the treatment of Narcolepsy associated with or without Cataplexy in USA
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
SUVN-G3031
Suven initiates MAD studies in phase 1 clinical trial for investigational compound SUVN-G3031
SUVN-G3031 is a potent, selective, brain penetrant and orally active Histamine H3 inverse agonist being developed for the…